IDEXX Laboratories (LTS:0J8P) ROCE % : 52.87% (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is IDEXX Laboratories ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. IDEXX Laboratories's annualized ROCE % for the quarter that ended in Sep. 2024 was 52.87%.

IDEXX Laboratories ROCE % Historical Data

The historical data trend for IDEXX Laboratories's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDEXX Laboratories ROCE % Chart

IDEXX Laboratories Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

59.05

49.32

55.09

56.51

57.75

IDEXX Laboratories Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															53.92	45.01	51.59	45.52	52.87

IDEXX Laboratories ROCE % Calculation

IDEXX Laboratories's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	1102.757	/	( ( (2746.765 - 1235.803)	+	(3259.925 - 951.547) )	/ 2 )
	=	1102.757	/	( (1510.962	+	2308.378)	/ 2 )
	=	1102.757	/	1909.67
	=	57.75 %

IDEXX Laboratories's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	1226.424	/	( ( (3414.867 - 1116.702)	+	(3350.766 - 1009.224) )	/ 2 )
	=	1226.424	/	( ( 2298.165	+	2341.542 )	/ 2 )
	=	1226.424	/	2319.8535
	=	52.87 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

IDEXX Laboratories (LTS:0J8P) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

IDEXX Laboratories ROCE % Related Terms

Thank you for viewing the detailed overview of IDEXX Laboratories's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

IDEXX Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDEXX Laboratories Inc (LTS:0J8P) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

IDXX:USA IDXX:Mexico IX1:Germany IX1:Germany I1DX34:Brazil IDXX:Austria

Address

One IDEXX Drive, Westbrook, ME, USA, 04092

Website

https://www.idexx.com

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.

IDEXX Laboratories Headlines

No Headlines